Journey Medical Corporation

NasdaqCM:DERM Voorraadrapport

Marktkapitalisatie: US$112.2m

Journey Medical Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Claude Maraoui

Algemeen directeur

US$934.5k

Totale compensatie

Percentage CEO-salaris58.9%
Dienstverband CEO10.2yrs
Eigendom CEO2.6%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur3yrs

Recente managementupdates

Recent updates

Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Oct 03
Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Mar 11
Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Jan 18
Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Nov 10
Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

May 12
US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

Analyse CEO-vergoeding

Hoe is Claude Maraoui's beloning veranderd ten opzichte van Journey Medical's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$18m

Jun 30 2024n/an/a

US$843k

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$934kUS$550k

-US$4m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$39m

Mar 31 2023n/an/a

-US$38m

Dec 31 2022US$2mUS$474k

-US$30m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$41m

Mar 31 2022n/an/a

-US$46m

Dec 31 2021US$2mUS$464k

-US$44m

Sep 30 2021n/an/a

-US$20m

Jun 30 2021n/an/a

-US$9m

Mar 31 2021n/an/a

US$4m

Dec 31 2020US$2mUS$450k

US$5m

Compensatie versus markt: De totale vergoeding ($USD 934.45K ) Claude } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 647.72K ).

Compensatie versus inkomsten: De vergoeding van Claude is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Claude Maraoui (57 yo)

10.2yrs

Tenure

US$934,450

Compensatie

Mr. Claude Maraoui is Founder and Director of Journey Medical Corporation since 2016 and its President and Chief Executive Officer since September 2014. Mr. Maraoui has experience in launching and commerci...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Lindsay Rosenwald
Executive Chairman10.1yrsUS$50.00k1.54%
$ 1.7m
Claude Maraoui
Founder8.8yrsUS$934.45k2.59%
$ 2.9m
Michael Pearce
Directorless than a yeargeen gegevensgeen gegevens
Neil Herskowitz
Independent Director3yrsUS$110.00k0.21%
$ 237.6k
Justin Smith
Independent Director3yrsUS$100.00k0.51%
$ 575.9k
Miranda Toledano
Independent Director3yrsUS$100.00k0.21%
$ 237.6k

3.0yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van DERM wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).